Published in Am J Med on October 01, 1976
Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol (2011) 1.26
Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2008) 1.11
Endocrine myopathies. Br Med J (Clin Res Ed) (1983) 1.04
Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int (2005) 0.99
Laboratory evaluation of the inflammatory myopathies. Clin Diagn Lab Immunol (1995) 0.88
Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab (2013) 0.86
Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. J Clin Invest (1993) 0.85
Corticosteroid effects on ventilator-induced diaphragm dysfunction in anesthetized rats depend on the dose administered. Respir Res (2010) 0.77
Myopathies of endocrine disorders: A prospective clinical and biochemical study. Ann Indian Acad Neurol (2014) 0.76
Role of Myofibrillar Protein Catabolism in Development of Glucocorticoid Myopathy: Aging and Functional Activity Aspects. Metabolites (2016) 0.76
Managing early presentation of rheumatoid arthritis. Systematic overview. Can Fam Physician (1996) 0.75
Acute myopathy secondary to oral steroid therapy in a 49-year-old man: a case report. J Med Case Rep (2011) 0.75
Iatrogenic neuromuscular disorders: a review. J R Soc Med (1983) 0.75
Central nervous system rendez-vous--canine progressive posterior paresis. Can Vet J (1996) 0.75
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum (1995) 5.32
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
Unstable angina pectoris. N Engl J Med (2000) 3.58
Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum (1995) 3.05
Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc Natl Acad Sci U S A (1990) 2.79
Current concepts of degenerative joint disease (osteoarthritis). Bull Rheum Dis (1967) 2.08
Impact of chronic kidney disease on postoperative outcome following colorectal cancer surgery. Colorectal Dis (2014) 2.04
Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N Engl J Med (1990) 1.93
Estrogens and osteoarthritis. Clin Orthop Relat Res (1986) 1.83
Pulmonary function in Duchenne muscular dystrophy related to stage of disease. Am J Med (1974) 1.76
Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem (2000) 1.63
Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem (2000) 1.60
Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem (1999) 1.52
Uptake of some quaternary ammonium ions by human erythrocytes. J Gen Physiol (1966) 1.52
Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J Biol Chem (1998) 1.51
Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. J Rheumatol (1990) 1.49
Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol (2009) 1.44
Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2. J Biol Chem (2001) 1.28
Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum (1973) 1.25
Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes (Lond) (2006) 1.20
Sjögren's syndrome: a critical review of clinical management. J Rheumatol (1999) 1.20
Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction. Metabolism (1973) 1.19
Partial inhibition of Na+/K+-ATPase by ouabain induces the Ca2+-dependent expressions of early-response genes in cardiac myocytes. J Biol Chem (1996) 1.19
Comprehensive outpatient care in rheumatoid arthritis. A controlled study. JAMA (1968) 1.17
Crystal-induced inflammation associated with chronic renal failure treated with periodic hemodialysis. Am J Med (1969) 1.14
Chondrocalcinosis and chondrocalsynovitis. (pseudogout syndrome). Analysis of twenty-four cases. Am J Med (1967) 1.11
Clinical correlations of osteoarthritis associated with a single-base mutation (arginine519 to cysteine) in type II procollagen gene. A newly defined pathogenesis. Arthritis Rheum (1994) 1.10
Studies of osteophyte pathogenesis in experimentally induced osteoarthritis. J Rheumatol (1987) 1.08
Comprehensive care and psycho-social factors in rehabilitation in chronic rheumatoid arthritis: a controlled study. J Chronic Dis (1972) 1.07
Generation of kinin-like agents by chondroitin sulfate, heparin, chitin sulfate, and human articular cartilage: possible pathophysiologic implications. J Lab Clin Med (1970) 1.06
The effect of exercise in muscular dystrophy. JAMA (1966) 1.05
Bacterial inactivation of human serum alpha-1 antitrypsin. J Lab Clin Med (1971) 1.04
Physicochemical properties of the aging and diabetic sand rat intervertebral disc. J Orthop Res (1992) 1.03
Type II procollagen gene (COL2A1) mutation in exon 11 associated with spondyloepiphyseal dysplasia, tall stature and precocious osteoarthritis. J Rheumatol (1995) 1.02
Introduction to OARSI FDA initiative OAC special edition. Osteoarthritis Cartilage (2011) 1.02
Experimentally induced corticosteroid arthropathy. Arthritis Rheum (1970) 1.02
Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am (1999) 1.01
Serum keratan sulfate. Quantitative and qualitative comparisons in inflammatory versus noninflammatory arthritides. Arthritis Rheum (1991) 1.00
Physical models of rehabilitation in neuromuscular disease. Muscle Nerve (1983) 1.00
Adoptive transfer of suppression of arthritis in the mouse model of collagen-induced arthritis. Evidence for a type II collagen-specific suppressor T cell. J Clin Invest (1985) 1.00
Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip. J Int Med Res (2002) 1.00
Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis--insulin, insulin-like growth factor-I, growth hormone. J Rheumatol (1994) 0.99
Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun (2000) 0.99
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation. Arthritis Rheum (1999) 0.98
Evaluation of laboratory tests in diagnosis and management of polymyositis. Am J Med Sci (1972) 0.97
Genetics and osteoarthritis: exposing the iceberg. Arthritis Rheum (1999) 0.97
Determination of total (Na+ + K+)-ATPase activity of isolated or cultured cells. Anal Biochem (1989) 0.97
Estradiol receptors in articular chondrocytes. Biochem Biophys Res Commun (1982) 0.97
Cartilage expression of a type II collagen mutation in an inherited form of osteoarthritis associated with a mild chondrodysplasia. J Clin Invest (1991) 0.97
Arthritis of hemochromatosis. Clinical spectrum, relation to histocompatibility antigens, and effectiveness of early phlebotomy. Am J Med (1983) 0.97
Cartilage proteoglycan alterations in an experimentally induced model of rabbit osteoarthritis. Arthritis Rheum (1979) 0.96
Classification criteria for systemic lupus erythematosus. Frequency in normal patients. JAMA (1976) 0.96
Design and conduct of clinical trials in osteoarthritis: preliminary recommendations from a task force of the Osteoarthritis Research Society. J Rheumatol (1997) 0.95
Early-onset primary osteoarthritis and mild chondrodysplasia. Radiographic and pathologic studies with an analysis of cartilage proteoglycans. Arthritis Rheum (1990) 0.93
Eosinophilic fasciitis: clinical, laboratory, and microscopic considerations. Arthritis Rheum (1981) 0.92
Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families. Am J Med (1984) 0.91
Coxibs and NSAIDs--is the air any clearer? Perspectives from the OARSI/International COX-2 Study Group Workshop 2007. Osteoarthritis Cartilage (2007) 0.91
Correlation of the biosynthesis of prostaglandin and cyclic AMP in monolayer cultures of rabbit articular chondrocytes. Biochim Biophys Acta (1982) 0.91
(Na+ + K+)-ATPase: on the number of the ATP sites of the functional unit. J Bioenerg Biomembr (1987) 0.90
Experimental models of degenerative joint disease. Semin Arthritis Rheum (1972) 0.90
Assessment of hand function in Duchenne muscular dystrophy. Arch Phys Med Rehabil (1993) 0.90
Regulation of AMP deaminase by 2,3-diphosphoglyceric acid: a possible mechanism for the control of adenine nucleotide metabolism in human erythrocytes. Biochim Biophys Acta (1968) 0.90
Peripheral ischemia and collagen disease: clinical manifestations, diagnosis, and treatment. Arch Surg (1972) 0.89
Mechanisms of detergent effects on membrane-bound (Na+ + K+)-ATPase. J Biol Chem (1985) 0.89
Hereditary osteoarthritis with mild spondyloepiphyseal dysplasia--are there "hot spots" on COL2A1? J Rheumatol (1996) 0.89
Echocardiographic evaluation of left ventricular function in Duchenne's muscular dystrophy. Am J Med (1980) 0.89
The effects of antibodies to Na+, K+-ATPase on the reactions catalyzed by the enzyme. Ann N Y Acad Sci (1974) 0.89
Alkali cation-activated AMP deaminase of erythrocytes: some properties of the membrane-bound enzyme. Biochim Biophys Acta (1968) 0.89
Biomechanical, radiologic, and histopathologic correlations in the pathogenesis of experimental intervertebral disc disease. Spine (Phila Pa 1976) (1994) 0.88
Different oligomycin sensitivities of the Na++K+-activated adenosinetriphosphatase and its partial reactions. Biochem Biophys Res Commun (1968) 0.88
Metabolic responses of cartilage in experimentally induced osteoarthritis. Ann Rheum Dis (1981) 0.88
(Na+ + K+)-dependent adenosine triphosphatase. Regulation of inorganic phosphate, magnesium ion, and calcium ion interactions with the enzyme by ouabain. J Biol Chem (1983) 0.88
Different sensitivities of the Na+/K(+)-ATPase isoforms to oxidants. Biochim Biophys Acta (1994) 0.88
Subunit associations of (Na+ + K+)-dependent adenosine triphosphatase. Chemical cross-linking studies. J Biol Chem (1983) 0.88
Vesicoureteral reflux in black girls. J Urol (1982) 0.87
Evaluation of a clinic education program for patients with rheumatoid arthritis. J Rheumatol (1976) 0.87
Zinc, copper, and parenteral nutrition in cancer. A review. JPEN J Parenter Enteral Nutr (1981) 0.87
Na+,K+-ATPase: on the nature of the "cross-linked" subunits obtained in the presence of o-phenanthroline and cupric ion. Biochem Biophys Res Commun (1978) 0.87
Pathologic and metabolic responses of experimental osteoarthritis to estradiol and an estradiol antagonist. Clin Orthop Relat Res (1983) 0.87
Evaluation of pulmonary hypertrophic osteoarthropathy in cystic fibrosis. A comprehensive study. Am J Dis Child (1986) 0.87
Osteoarthritis: simple analgesics versus nonsteroidal antiinflammatory drugs. J Rheumatol (2001) 0.87
Effects of estrogen on cartilage and experimentally induced osteoarthritis. Arthritis Rheum (1979) 0.87
Human serum necrotizing factor: basic properties and clinical significance. J Lab Clin Med (1965) 0.86
The American Board of Internal Medicine recertification program in rheumatology. Arthritis Rheum (1995) 0.86
Urinary sodium, potassium and aldosterone in Duchenne muscular dystrophy. J Clin Endocrinol Metab (1977) 0.86
Immunoglobulin G-induced experimental chronic immune synovitis: cell-mediated immunity to native interstitial collagen molecules and their constituent polypeptide chains. Cell Immunol (1984) 0.86
Degenerative joint changes following posterior cruciate ligament section in the rabbit. Clin Orthop Relat Res (1973) 0.86
Red cell Na+,K+-ATPase: a method for estimating the extent of inhibition of an enzyme sample containing an unknown amount of bound cardiac glycoside. Life Sci (1975) 0.86
Effects of doxorubicin on cardiomyocytes with reduced level of superoxide dismutase. Life Sci (1995) 0.86
Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis. Arthritis Rheum (1994) 0.86
Five families with arginine 519-cysteine mutation in COL2A1: evidence for three distinct founders. Hum Mutat (1998) 0.85
Modifying effects of anions on the alkali-cation-activated AMP deaminase of human erythrocyte. Mol Pharmacol (1966) 0.85
Eosinophilic fasciitis. Immunopathology, ultrastructure, literature review, and consideration of its pathogenesis and relation to scleroderma. Arch Pathol Lab Med (1982) 0.85
Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage (2008) 0.85
Lysyl oxidase and Maillard reaction-mediated crosslinks in aging and osteoarthritic rabbit cartilage. J Orthop Res (1995) 0.85
Metabolic studies in experimentally-induced degenerative joint disease in the rabbit. J Rheumatol (1974) 0.84